Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.
This report contains market size and forecasts of Tinea Corporis Drugs in Global, including the following market information:
Global Tinea Corporis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tinea Corporis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antifungals Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tinea Corporis Drugs include Sun Pharmaceutical, Teva, Glenmark, Aurobindo, AvKare, Novartis, Sebela and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tinea Corporis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tinea Corporis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tinea Corporis Drugs Market Segment Percentages, by Type, 2021 (%)
Antifungals
Steroids
Anti-Infective Combinations
Global Tinea Corporis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tinea Corporis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Tinea Corporis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tinea Corporis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tinea Corporis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tinea Corporis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharmaceutical
Teva
Glenmark
Aurobindo
AvKare
Novartis
Sebela
Bayer